Today

Agents

Chat

Arena

Discover

More

App

NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 Million - NEO News | Rallies

NeoGenomics Q2 Revenue USD 202 Million Vs. IBES Estimate USD 197 Million

NEO•2026-07-28

NeoGenomics reports second-quarter financial results

Jul 28 (Reuters) - NeoGenomics Q2 adjusted EBITDA USD 14 million.

Q2 operating expenses USD 102 million
Q2 adjusted net income USD 7 million
Q2 gross profit USD 92 million
Q2 net income USD 2 million

Related News

Arlo grants 65,624 RSUs to eight new employees under 2018 equity plan

ARLO•2026-07-28

Seritage Growth Properties signs USD 40 million loan facilities with b1Bank

SRG•2026-07-28

First Busey Q2 adjusted EPS tops estimates on higher wealth management fee

•

2026-07-28

HF Sinclair general counsel Eric Nitcher retires from executive role July 31

DINO•2026-07-28

Black Hills declares quarterly dividend of $0.7 a share

BKH•2026-07-28